Cargando…

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

Detalles Bibliográficos
Autores principales: Bjoern, Jon, Lyngaa, Rikke, Andersen, Rikke, Hölmich, Lisbet Rosenkrantz, Hadrup, Sine Reker, Donia, Marco, Svane, Inge Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254673/
https://www.ncbi.nlm.nih.gov/pubmed/30533201
http://dx.doi.org/10.18632/oncotarget.26359
_version_ 1783373777523965952
author Bjoern, Jon
Lyngaa, Rikke
Andersen, Rikke
Hölmich, Lisbet Rosenkrantz
Hadrup, Sine Reker
Donia, Marco
Svane, Inge Marie
author_facet Bjoern, Jon
Lyngaa, Rikke
Andersen, Rikke
Hölmich, Lisbet Rosenkrantz
Hadrup, Sine Reker
Donia, Marco
Svane, Inge Marie
author_sort Bjoern, Jon
collection PubMed
description
format Online
Article
Text
id pubmed-6254673
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62546732018-12-07 Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma Bjoern, Jon Lyngaa, Rikke Andersen, Rikke Hölmich, Lisbet Rosenkrantz Hadrup, Sine Reker Donia, Marco Svane, Inge Marie Oncotarget Correction Impact Journals LLC 2018-11-09 /pmc/articles/PMC6254673/ /pubmed/30533201 http://dx.doi.org/10.18632/oncotarget.26359 Text en Copyright: © 2018 Bjoern et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Bjoern, Jon
Lyngaa, Rikke
Andersen, Rikke
Hölmich, Lisbet Rosenkrantz
Hadrup, Sine Reker
Donia, Marco
Svane, Inge Marie
Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
title Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
title_full Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
title_fullStr Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
title_full_unstemmed Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
title_short Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
title_sort correction: influence of ipilimumab on expanded tumour derived t cells from patients with metastatic melanoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254673/
https://www.ncbi.nlm.nih.gov/pubmed/30533201
http://dx.doi.org/10.18632/oncotarget.26359
work_keys_str_mv AT bjoernjon correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma
AT lyngaarikke correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma
AT andersenrikke correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma
AT holmichlisbetrosenkrantz correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma
AT hadrupsinereker correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma
AT doniamarco correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma
AT svaneingemarie correctioninfluenceofipilimumabonexpandedtumourderivedtcellsfrompatientswithmetastaticmelanoma